Melanoma, a tumor based on a mutant stem cell? - PubMed (original) (raw)
. 2006 Jan;126(1):142-53.
doi: 10.1038/sj.jid.5700017.
Affiliations
- PMID: 16417230
- DOI: 10.1038/sj.jid.5700017
Free article
Melanoma, a tumor based on a mutant stem cell?
James M Grichnik et al. J Invest Dermatol. 2006 Jan.
Free article
Abstract
Stem cells play a critical role in normal tissue maintenance, and mutations in these stem cells may give rise to cancer. We hypothesize that melanoma develops from a mutated stem cell and therefore residual stem cell characteristics should be able to be identified in melanoma cell lines. We studied three metastatic melanoma cell lines that exhibited multiple morphologic forms in culture and demonstrated the capacity to pigment. We used the ability to efflux Hoechst 33342 dye, a technique known to enrich for stem cells in many tissues, to segregate cell populations. The cells with the greatest ability to efflux the dye were (1) small in size, (2) had the capacity to give rise to larger cell forms, and (3) had the greatest ability to expand in culture. The small cells were found to have a decreased proliferative rate and were less melanized. Large dendritic cells that appeared to be nonproliferative were identified in cultures. Treatment with cytosine beta-D-arabinofuranoside hydrochloride (Ara-C) expanded the large cell population but the residual proliferative capacity, both in vitro and in vivo, remained concentrated in the smaller cell fraction. Antigenic staining patterns were variable and heterogeneous. Nestin (a neural stem cell marker) and gp100 (premelanosomal marker) favored the smaller cell population, while nerve growth factor receptor often labeled larger cells. Morphologic and antigenic heterogeneity remained intact after clonal purification. These findings are consistent with the behavior expected for a tumor based on stem cell biology; this finding has diagnostic and therapeutic implications for melanocytic neoplasias.
Similar articles
- Increased expression of stem cell markers in malignant melanoma.
Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, Tahan SR. Klein WM, et al. Mod Pathol. 2007 Jan;20(1):102-7. doi: 10.1038/modpathol.3800720. Epub 2006 Nov 24. Mod Pathol. 2007. PMID: 17143262 - Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma.
Akiyama M, Matsuda Y, Ishiwata T, Naito Z, Kawana S. Akiyama M, et al. J Invest Dermatol. 2013 May;133(5):1384-7. doi: 10.1038/jid.2012.508. Epub 2013 Feb 7. J Invest Dermatol. 2013. PMID: 23389394 No abstract available. - Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.
Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H, Lee BH, Park JH. Na YR, et al. Tumour Biol. 2009;30(5-6):300-9. doi: 10.1159/000261073. Epub 2009 Nov 23. Tumour Biol. 2009. PMID: 19940551 - Melanoma stem cells: the dark seed of melanoma.
Zabierowski SE, Herlyn M. Zabierowski SE, et al. J Clin Oncol. 2008 Jun 10;26(17):2890-4. doi: 10.1200/JCO.2007.15.5465. J Clin Oncol. 2008. PMID: 18539969 Review. - Melanoma stem cells.
Roesch A. Roesch A. J Dtsch Dermatol Ges. 2015 Feb;13(2):118-24. doi: 10.1111/ddg.12584. J Dtsch Dermatol Ges. 2015. PMID: 25631128 Review. English, German.
Cited by
- Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis.
Tucci M, D'Oronzo S, Mannavola F, Felici C, Lovero D, Cafforio P, Palmirotta R, Silvestris F. Tucci M, et al. Ther Adv Med Oncol. 2020 Mar 13;12:1758835920905415. doi: 10.1177/1758835920905415. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32206092 Free PMC article. - Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability.
Raineri A, Fasoli S, Campagnari R, Gotte G, Menegazzi M. Raineri A, et al. Int J Mol Sci. 2019 Nov 27;20(23):5980. doi: 10.3390/ijms20235980. Int J Mol Sci. 2019. PMID: 31783660 Free PMC article. - CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition.
Simbulan-Rosenthal CM, Gaur A, Zhou H, AbdusSamad M, Qin Q, Dougherty R, Aljehane L, Kuo LW, Vakili S, Karna K, Clark H, McCarron E, Rosenthal DS. Simbulan-Rosenthal CM, et al. J Oncol. 2019 Jul 16;2019:6486173. doi: 10.1155/2019/6486173. eCollection 2019. J Oncol. 2019. PMID: 31379943 Free PMC article. - Therapeutic potential of bleomycin plus suicide or interferon-β gene transfer combination for spontaneous feline and canine melanoma.
Agnetti L, Fondello C, Villaverde MS, Glikin GC, Finocchiaro LME. Agnetti L, et al. Oncoscience. 2017 Dec 28;4(11-12):199-214. doi: 10.18632/oncoscience.387. eCollection 2017 Nov. Oncoscience. 2017. PMID: 29344558 Free PMC article. - SOX10-MITF pathway activity in melanoma cells.
Tudrej KB, Czepielewska E, Kozłowska-Wojciechowska M. Tudrej KB, et al. Arch Med Sci. 2017 Oct;13(6):1493-1503. doi: 10.5114/aoms.2016.60655. Epub 2016 Jun 17. Arch Med Sci. 2017. PMID: 29181082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical